JPRN-jRCT2080221674未知2 期
Phase III Clinical Study of DU-176b (non-valvular atrial fibrillation): Japanese, Multicenter, Open-label Study of DU-176b in Patients with non-valvular atrial fibrillation and Severe Renal Impairment
适应症
试验速览
- 阶段
- 2 期
- 入组人数
- 90
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- >= 20age old 至 ot applicable（—）
- 性别
- All
入选标准
- •Patients with non-valvular atrial fibrillation and severe renal impairment, or normal renal function or mild renal impairment
排除标准
- •-Patients on hemodialysis or patients who may start hemodialysis before the follow-up assessment
- •-Patients at risk for bleeding
- •-Patients who are receiving treatment with any anticoagulant drugs excluding warfarin and dabigatran
- •-Patients with evidence of hepatic dysfunction
研究者
相似试验
已完成
3 期
Safety and Pharmacokinetics Study of DU-176b Administered to Non-valvular Atrial Fibrillation With Severe Renal ImpairmentNon-valvular Atrial FibrillationNCT01857622Daiichi Sankyo Co., Ltd.93
未知
3 期
DU-176b Phase III Clinical Study (Venous Thromboembolism) Randomized Double-Blind Study of DU-176b in Patients Undergoing Total Hip Arthroplasty with Enoxaparin as an Active ControlJPRN-jRCT2080220743DAIICHISANKYO Co.,Ltd.600
未知
3 期
DU-176b Phase III Clinical Study (Venous Thromboembolism) -A multicenter, Randomized, Unblinded Study of DU-176b in Patients Undergoing Hip Fracture Surgery with Enoxaparin as a referencePatients undergoing hip fracture surgeryJPRN-jRCT2080220770DAIICHISANKYO Co.,Ltd.90
未知
3 期
DU-176b Phase 3 Clinical Study (Venous Thromboembolism) -Randomized Double-Blind Study of DU-176b in Patients Undergoing Total Knee Arthroplasty with Enoxaparin as an Active ControlJPRN-jRCT2080220701DAIICHISANKYO Co.,Ltd.520
未知
3 期
Phase 3 clinical study of DU-6859a in patients with respiratory tract infectioJPRN-jRCT2080220704DAIICHISANKYO Co.,Ltd.150